Back to Search Start Over

Simulation study using the spots deletion technique in spot scanning proton beam therapy for prostate cancers.

Authors :
Fukumitsu N
Hayakawa T
Yamashita T
Mima M
Demizu Y
Suzuki T
Soejima T
Source :
Molecular and clinical oncology [Mol Clin Oncol] 2022 Jan; Vol. 16 (1), pp. 25. Date of Electronic Publication: 2021 Dec 01.
Publication Year :
2022

Abstract

The aim of the present study was to investigate the effects on the dose distribution and beam delivery time in spot scanning proton beam therapy (PBT) incorporating the spot deletion technique. A spot scanning plan was created for 30 patients with prostate cancer. The plan was then modified via two processes: Spots with lower weighting depositions were deleted (process A) and spots that were distant from the clinical target volume (CTV) were deleted (process B). The dose distribution to the organs at risk (OAR), the expanded CTV (exCTV), which was defined by a uniform expansion of the CTV by a radius of 5 mm, and the beam delivery time were compared among initial and modified plans. The V <subscript>50</subscript> <subscript>Gy [relative biological effectiveness (RBE)]</subscript> to the rectum and bladder, and V <subscript>60 Gy(RBE)</subscript> to the urethral bulb, inhomogeneity index (INH) of the exCTV showed a difference (P=1.1x10 <superscript>-14</superscript> , P=6.4x10 <superscript>-14</superscript> , P=2.7x10 <superscript>-7</superscript> , P=3.2x10 <superscript>-17</superscript> ), although only changes by process B were significant. Modified plan by process B showed the V <subscript>50 Gy(RBE)</subscript> to the rectum and bladder decreased by -2.4±1.6 and -2.3±1.4%, and the V <subscript>60 Gy (RBE)</subscript> to the urethral bulb decreased by -15.9±19.4%. The INH of the exCTV increased by 0.05±0.03%. On the other hand, modification of the initial plan by process A did not affect the dose of the OAR, exCTV or beam delivery time. In spot scanning PBT, modification of the initial radiotherapy plan by systemic deletion of spots distant from the CTV could result in a dose reduction to the OAR.<br />Competing Interests: The authors declare that they have no competing interests.<br /> (Copyright: © Fukumitsu et al.)

Details

Language :
English
ISSN :
2049-9469
Volume :
16
Issue :
1
Database :
MEDLINE
Journal :
Molecular and clinical oncology
Publication Type :
Academic Journal
Accession number :
34909203
Full Text :
https://doi.org/10.3892/mco.2021.2458